Table 2.
n = 26 | % | |
---|---|---|
Morphology of GCLR | ||
– papules – plaques – papulovesicles – urticarial papules/plaques – target‐like papules/plaques |
26 12 4 2 2 |
100 46 15 8 8 |
Affected body areas | ||
– extremities – upper extremities – accentuation over extensor surfaces/elbows – dorsal hands – palms – lower extremities – accentuation over extensor surfaces/knees – Achilles tendon – dorsal feet – soles – face – trunk – buttocks |
26 25 22 7 1 23 18 4 6 1 6 7 5 |
100 96 85 27 4 88 69 15 23 4 23 27 19 |
Severity of GCLR (PGA) | ||
– 4 – 3 – 2 – 1 |
1 10 9 6 |
4 38 35 23 |
Symptoms associated with GCLR | ||
– pruritus – pain – asymptomatic |
20 1 5 |
77 4 19 |
Treatment for GCLR performed | ||
– yes – no |
20 6 |
77 23 |
Total duration of GCLR (days; median, range)* | 23.5 (10–150) | |
Resolution of MC after GCLR | ||
– yes – unknown |
21 5 |
81 19 |
Time until resolution of MC after onset of GCLR (weeks; median, range) | 9 (4–24) |
Information available for 18 patients (69 %).